April 27, 2005
$65 Million Settlement in Paxil lawsuit
"A federal judge has granted final approval to SmithKline Beecham's $65 million settlement of a class action antitrust suit brought by consumers who said they paid inflated prices for Paxil, a popular anti-depressant drug.
"The suit alleged that SmithKline illegally maintained a monopoly by filing a series of "sham" patent lawsuits that were designed to delay any generic version of the drug from reaching the market."
April 27, 2005 | Permalink
TrackBack URL for this entry:
Listed below are links to weblogs that reference $65 Million Settlement in Paxil lawsuit: